艾司氯胺酮麻醉诱导对眼循环的差异化影响: 一项随机对照研究

Differential effects of esketamine anesthesia induction on ocular circulation: a randomized controlled study

  • 摘要:
    目的 探讨艾司氯胺酮麻醉诱导对眼循环和颅内压的影响。
    方法 选择2023年1—9月在扬州大学附属医院择期行锁骨手术全身麻醉的60例患者为研究对象,随机分为S组(n=30)和C组(n=30)。麻醉诱导前,静脉给予1.5 mg/kg丙泊酚镇静,随后S组给予0.5 mg/kg艾司氯胺酮,对照组给予等量生理盐水。采用彩色多普勒超声在丙泊酚镇静2 min后(T1)、气管插管5 min后(T2)和术毕拔管前(T3)3个时点,分别检测眼动脉(OA)和视网膜中央动脉部位的血流动力学参数,包括收缩期峰值流速(PSV)、舒张末期流速(EDV)和阻力指数(RI), 并测量视神经鞘直径(ONSD)。
    结果 T2时点, S组ONSD较C组增宽,眼动脉部位PSV与EDV较C组增加, RI较C组降低,差异均有统计学意义(P < 0.05)。T2时点, 2组ONSD较T1时点增宽,眼动脉和视网膜中央动脉部位的PSV与EDV均较T1时点增加, RI在眼动脉部位较T1时点降低,差异均有统计学意义(P < 0.05)。T2时点, S组HR与MAP均高于C组,差异有统计学意义(P < 0.05); 与T1时点比较, S组T2时点HR与MAP升高,差异有统计学意义(P < 0.05)。S组瑞芬太尼用量较C组减少,差异有统计学意义(P < 0.05)。2组丙泊酚用量和不良反应发生率差异无统计学意义(P>0.05)。
    结论 单次静脉注射0.5 mg/kg艾司氯胺酮可使ONSD轻度增加,但不影响颅内压。艾司氯胺酮对眼循环血管具有选择性作用,可增加眼动脉血流速度,而对视网膜中央动脉的血流无明显影响。

     

    Abstract:
    Objective To investigate the effects of esketamine anesthesia induction on ocular circulation and intracranial pressure.
    Methods A total of 60 patients who underwent elective clavicle surgery under general anesthesia at the Affiliated Hospital of Yangzhou University from January to September 2023 were selected as study subjects and randomly divided into group S (n=30) and group C (n=30). Before anesthesia induction, 1.5 mg/kg of propofol was administered intravenously for sedation. Subsequently, group S received 0.5 mg/kg of esketamine, while the control group received an equal volume of normal saline. Color Doppler ultrasound was used to measure the hemodynamic parameters of the ophthalmic artery (OA) and central retinal artery at three time points: 2 minutes after propofol sedation (T1), 5 minutes after tracheal intubation (T2), and before extubation at the end of surgery (T3). These parameters includedpeak systolic velocity (PSV), end-diastolic velocity (EDV), and resistance index (RI). Additionally, the optic nerve sheath diameter (ONSD) was measured.
    Results At the T2, the ONSD in the group S was wider than that in the group C, the PSV and EDV at the ophthalmic artery site were higher than those in the group C, and the RI was lower than that in the group C (P < 0.05). At the T2, the ONSD in both groups was wider than that at the T1, the PSV and EDV at the ophthalmic artery and central retinal artery sites were higher than those at the T1, and the RI at the ophthalmic artery site was lower than that at the T1 (P < 0.05). At the T2, the heart rate (HR) and mean arterial pressure (MAP) in the group S were higher than those in the group C (P < 0.05). Compared with the T1, the HR and MAP in the group S at the T2 were elevated (P < 0.05). The dosage of remifentanil in the group S was lower than that in the group C (P < 0.05). There were no statistically significant differences in the dosage of propofol and the incidence of adverse reactions between the two groups (P>0.05).
    Conclusion A single intravenous injection of 0.5 mg/kg of esketamine can slightly increase the ONSD but does not affect intracranial pressure. Esketamine has a selective effect on ocular circulation vessels, increasing the blood flow velocity of the ophthalmic artery while having no significant effect on the blood flow of the central retinal artery.

     

/

返回文章
返回